Skip to main content
Equibles

GENX · Genix Pharmaceuticals Corporation

Use GENX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GENX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.0200 CAD +0.0050 (+33.33%) At close · Nov 4 Intraday price with Plus
Rebalance outlook locked
Market Cap
1.22M CAD
Shares
61.22M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close0.0200 CAD Open0.0200 CAD Day0.0200–0.0200 CAD 52W close0.0150–0.0300 CAD Avg vol 30d119K DataJan 2020–Nov 2026

Latest documents

2026
Jun 26
Report SEDAR+
MD&A
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.0150 CAD Now 0.0200 CAD · 33% Range high 0.0300 CAD
vs 200-day avg -63% vs 50-day avg -34%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSX:GENX +0.0% -33.3% -50.0% +33.3% -33.3%

Exchange listing

Market
XTSX
Ticker
GENX
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company

Website
https://genixpharm.com/
Investor relations
https://genixpharm.com/investors/

Other listings of this company

No other verified listings are available.

Latest price

Plus & Pro

Follow GENX during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.